InvestorsHub Logo
Followers 90
Posts 18119
Boards Moderated 0
Alias Born 09/06/2006

Re: drugrunner post# 705833

Saturday, 07/13/2024 1:46:53 PM

Saturday, July 13, 2024 1:46:53 PM

Post# of 732516

.. what is potentially at worst an excellent treatment ...


And therein lies the issue.

They ran a randomized trial where 233 patients received DC-L and 99 received placebo. The 233 did no better than the 99. Not on either PFS nor OS. That is far from an excellent treatment, it is more like grape fruit juice.

Longs can say but, but, but all day long. But reality is approval based on the P3 looks very questionable.

Even if DC-L does work (which I think is possible, but not clear), the value is not much if they have to run another trial. And neither of the combo trials that longs want to hype will do the trick.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News